主辦 / 主持人
Takayuki Goto, Rupert Ouyang, Chia-Cheng Yu
積分
聯絡人
TUA
活動日期
2025-08-16 (六) 13:30 ~ 15:00
地點
TICC - 1F 101D
2025-08-16 TICC - 1F 101D
時間主題
13:30 ~ 13:36
#1096 High-Grade Undifferentiated Prostate Malignancy in a Young Aboriginal Male: A Case Report
講者: Rowan Klein Nulend 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
13:36 ~ 13:42
#1098 Hereditary Prostate Cancer: A Case Report of a Cancer Pedigree
講者: Le Dung Tran 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
13:42 ~ 13:48
#62 Combining percentage prostate-specific antigen reduction and multiparametric magnetic resonance imaging to reduce unnecessary biopsy after focal therapy with high-intensity focused ultrasound for prostate cancer
講者: Po-Fan Hsieh 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
13:48 ~ 13:54
#1109 Prevalence of prostate cancer among men undergoing TRUS guided prostatic biopsies, with correlation of serum PSA levels and distribution of Gleason grade groups: A single tertiary care centre experience.
講者: Ragavan Narasimhan 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
13:54 ~ 14:00
#666 Genitourinary toxicity following radiation therapy is not just about haematuria- lessons from 7 years of a specialist radiation cystitis clinic.
講者: Jonathan Kam 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
14:00 ~ 14:06
#668 Intraductal Carcinoma in Localised Prostate Cancer is Over-Represented in Patients with No Intraprostatic Uptake Pattern on PSMA PET
講者: Zein Alhamdani 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
14:06 ~ 14:12
#676 Reevaluating Role of Vitamin D in Prostate Cancer Pathology: The Impact of MRI-Guided Staging
講者: Sarita Chitjaroen 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
14:12 ~ 14:18
#684 Outcomes of Treatment for Localized Prostate Cancer in a Single Institution: Comparison of Radical Prostatectomy and Radiation Therapy Using Inverse Probability of Treatment Weighting (IPTW) Analysis
講者: Chih-Wei Chu 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
14:18 ~ 14:24
#776 Accuracy of Targeted Transrectal Ultrasound Prostate Biopsies
講者: Basil Razi 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
14:24 ~ 14:30
#816 A comparison between the Australian Cancer Council optimal care pathway for men with prostate cancer and the actual care in a public tertiary centre in Australia
講者: Thomas Milton 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
14:30 ~ 14:36
#834 The Role of 18F PSMA-1007 PET/CT in the Staging and Detection of Recurrence of Prostate Cancer. A Scoping Review.
講者: David Armany 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
14:36 ~ 14:42
#579 Circulating microRNA profiling for prediction of oncological outcomes in prostate cancer patients following radical prostatectomy
講者: Fumihiko Urabe 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
14:42 ~ 14:48
#704 Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer
講者: SHENG MA 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
14:48 ~ 14:54
#711 Discovery and Validation of Nitroolefin-Based Covalent GPX4 Inhibitors for Inducing Ferroptosis in Prostate Cancer
講者: Na Zeng 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu
14:54 ~ 15:00
#109 A research of burden and risk factors of prostate diseases from 1990 to 2021 in 21 regions and 204 territories
講者: Yiqun Tian 座長: Takayuki GOTO,
Rupert Ouyang,
Chia-Cheng Yu